KALV - SEC Form 4 insider transactions

CHIEF DEVELOPMENT OFFICER Yea Christopher exercised 33,800 shares at a strike of $7.07 and sold $905,225 worth of shares (33,800 units at $26.78) (SEC Form 4)

Chief Commercial Officer Sweeny Nicole sold $39,872 worth of shares (1,489 units at $26.78) and converted options into 5,000 shares, increasing direct ownership by 6% to 59,291 units (SEC Form 4) to cover withholding tax

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 5,000 shares and sold $59,955 worth of shares (2,239 units at $26.78), increasing direct ownership by 2% to 150,260 units (SEC Form 4) to satisfy tax liability

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 3,125 shares and sold $52,645 worth of shares (1,966 units at $26.78), increasing direct ownership by 0.51% to 229,918 units (SEC Form 4) (tax liability)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 23,250 shares and sold $292,646 worth of shares (10,926 units at $26.78), increasing direct ownership by 3% to 479,989 units (SEC Form 4) (tax withholding)

Chief Commercial Officer Sweeny Nicole converted options into 6,250 shares and sold $49,846 worth of shares (1,861 units at $26.78), increasing direct ownership by 9% to 55,780 units (SEC Form 4) to satisfy tax liability

CHIEF DEVELOPMENT OFFICER Yea Christopher sold $63,158 worth of shares (2,358 units at $26.78) and converted options into 3,750 shares, increasing direct ownership by 0.61% to 228,759 units (SEC Form 4) to satisfy withholding obligation

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 6,250 shares and sold $71,916 worth of shares (2,685 units at $26.78), increasing direct ownership by 2% to 147,499 units (SEC Form 4) to cover withholding tax

Chief Financial Officer Piekos Brian converted options into 5,000 shares and sold $39,882 worth of shares (1,489 units at $26.78), increasing direct ownership by 19% to 21,661 units (SEC Form 4) to cover withholding tax

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 1,774 shares and sold $29,650 worth of shares (1,108 units at $26.76), increasing direct ownership by 0.29% to 227,367 units (SEC Form 4) (tax liability)

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 2,419 shares and sold $27,616 worth of shares (1,032 units at $26.76), increasing direct ownership by 0.97% to 143,934 units (SEC Form 4) (withholding obligation)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 2,419 shares and sold $30,212 worth of shares (1,129 units at $26.76), increasing direct ownership by 0.28% to 467,665 units (SEC Form 4) to cover withholding tax

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 7,120 shares and sold $88,731 worth of shares (3,322 units at $26.71), increasing direct ownership by 0.82% to 466,375 units (SEC Form 4) to satisfy withholding obligation

SEC Form 4 filed by Audhya Paul K.

SEC Form 4 filed by Sweeny Nicole

SEC Form 4 filed by Piekos Brian

SEC Form 4 filed by Palleiko Benjamin L

SEC Form 4 filed by Venrock Healthcare Capital Partners Iii, L.P.

SEC Form 4 filed by KalVista Pharmaceuticals Inc.

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 11,250 shares and sold $83,345 worth of shares (5,354 units at $15.57), increasing direct ownership by 4% to 138,983 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 23,250 shares and sold $156,197 worth of shares (10,034 units at $15.57), increasing direct ownership by 3% to 442,883 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 6,875 shares and sold $67,669 worth of shares (4,347 units at $15.57), increasing direct ownership by 1% to 226,701 units (SEC Form 4)

Chief Commercial Officer Sweeny Nicole converted options into 11,250 shares and sold $61,878 worth of shares (3,975 units at $15.57), increasing direct ownership by 18% to 47,003 units (SEC Form 4)

Chief Financial Officer Piekos Brian converted options into 5,000 shares and sold $27,507 worth of shares (1,767 units at $15.57), increasing direct ownership by 31% to 13,762 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 2,419 shares and sold $15,570 worth of shares (1,038 units at $15.00), increasing direct ownership by 0.32% to 429,667 units (SEC Form 4)

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 2,419 shares and sold $17,445 worth of shares (1,163 units at $15.00), increasing direct ownership by 0.95% to 133,087 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 1,774 shares and sold $16,635 worth of shares (1,109 units at $15.00), increasing direct ownership by 0.30% to 224,173 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 7,120 shares and sold $52,658 worth of shares (3,354 units at $15.70), increasing direct ownership by 0.89% to 428,286 units (SEC Form 4)

SEC Form 4 filed by Chief Operations Officer Arif Bilal

SEC Form 4 filed by Chief Commercial Officer Sweeny Nicole

SEC Form 4 filed by Chief Financial Officer Piekos Brian

SEC Form 4 filed by CHIEF MEDICAL OFFICER Audhya Paul K.

SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 15,625 shares and sold $120,424 worth of shares (7,294 units at $16.51), increasing direct ownership by 2% to 424,520 units (SEC Form 4)

Chief Commercial Officer Sweeny Nicole sold $51,289 worth of shares (3,813 units at $13.45) and converted options into 11,250 shares, increasing direct ownership by 23% to 39,728 units (SEC Form 4)

Chief Financial Officer Piekos Brian converted options into 15,000 shares and sold $60,139 worth of shares (4,471 units at $13.45) (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 6,875 shares and sold $58,256 worth of shares (4,331 units at $13.45), increasing direct ownership by 1% to 223,508 units (SEC Form 4)

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 11,250 shares and sold $71,236 worth of shares (5,296 units at $13.45), increasing direct ownership by 5% to 131,831 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 23,250 shares and sold $147,154 worth of shares (10,940 units at $13.45), increasing direct ownership by 3% to 416,189 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher exercised 87,390 shares at a strike of $0.00, increasing direct ownership by 65% to 220,964 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L sold $64,665 worth of shares (4,466 units at $14.48) and converted options into 9,364 shares, increasing direct ownership by 1% to 403,879 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher sold $38,848 worth of shares (2,683 units at $14.48) and converted options into 4,205 shares, increasing direct ownership by 1% to 133,574 units (SEC Form 4)

CHIEF MEDICAL OFFICER Audhya Paul K. sold $44,524 worth of shares (3,075 units at $14.48) and converted options into 6,447 shares, increasing direct ownership by 3% to 125,877 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 7,120 shares and sold $38,438 worth of shares (3,328 units at $11.55), increasing direct ownership by 0.96% to 398,981 units (SEC Form 4)

SEC Form 4 filed by Chief Operations Officer Arif Bilal

SEC Form 4 filed by Director Pereira Brian Jg

SEC Form 4 filed by Director Stuart Nancy

SEC Form 4 filed by Director Treanor Patrick

SEC Form 4 filed by Director Fairey William

SEC Form 4 filed by Director Unkart Edward W

SEC Form 4 filed by Director Sensenig Bethany

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 15,625 shares and sold $115,537 worth of shares (7,294 units at $15.84), increasing direct ownership by 2% to 395,189 units (SEC Form 4)

Chief Commercial Officer Sweeny Nicole converted options into 5,000 shares and sold $19,862 worth of shares (1,480 units at $13.42), increasing direct ownership by 12% to 32,291 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 3,125 shares and sold $26,223 worth of shares (1,954 units at $13.42), increasing direct ownership by 0.89% to 132,052 units (SEC Form 4)

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 5,000 shares and sold $31,349 worth of shares (2,336 units at $13.42), increasing direct ownership by 2% to 122,505 units (SEC Form 4)

Chief Commercial Officer Sweeny Nicole converted options into 6,250 shares and sold $24,647 worth of shares (1,864 units at $13.22), increasing direct ownership by 18% to 28,771 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 3,750 shares and sold $31,232 worth of shares (2,362 units at $13.22), increasing direct ownership by 1% to 130,881 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 23,250 shares and sold $144,657 worth of shares (10,940 units at $13.22), increasing direct ownership by 3% to 386,858 units (SEC Form 4)

CHIEF MEDICAL OFFICER Audhya Paul K. sold $38,901 worth of shares (2,942 units at $13.22) and converted options into 6,250 shares, increasing direct ownership by 3% to 119,841 units (SEC Form 4)

CHIEF DEVELOPMENT OFFICER Yea Christopher converted options into 4,203 shares and sold $34,932 worth of shares (2,649 units at $13.19), increasing direct ownership by 1% to 129,493 units (SEC Form 4)